Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

924.07 -5.48 (-0.59%)

Streaming Delayed Price Updated: 3:08 PM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Could AbbVie Crash Lilly's Weight‑Loss Party? ↗

Today 13:20 EDT

AbbVie is making progress in this market, but it is still far behind the leader.

Via The Motley Fool

Amazon (AMZN) Stock Is Up, What You Need To Know

Today 13:06 EDT

What Happened? Shares of cloud computing and online retail behemoth Amazon (NASDAQ:AMZN) jumped 3.6% in the afternoon session after the company announced it ...

Via StockStory

Topics Artificial Intelligence

The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)

Today 9:47 EDT

As of today, April 14, 2026, the biotechnology landscape is being reshaped by a singular clinical milestone that many once deemed impossible. Just twenty-four hours ago, Revolution Medicines, Inc....

Via Finterra

Topics Economy Initial Public Offering Intellectual Property

Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years ↗

April 08, 2026

Via Benzinga

$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

April 13, 2026

Via Get News

Topics Intellectual Property

After Obtaining Approval for Its Weight Loss Pill, Is It Off to the Races for Eli Lilly Stock? ↗

April 13, 2026

In April, regulators approved Foundayo, Eli Lilly's GLP-1 pill for weight loss.

Via The Motley Fool

The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)

April 13, 2026

As of April 13, 2026, Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX) stands as a pivotal player in the rapidly evolving field of radiopharmaceuticals—a sector that has transformed from a niche...

Via Finterra

Topics Economy Initial Public Offering

The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026

April 13, 2026

As of today, April 13, 2026, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a titan of the biotechnology sector, representing a rare blend of scientific purity and commercial dominance. In an...

Via Finterra

Topics Earnings Economy Intellectual Property

Eli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients ↗

April 13, 2026

Eli Lilly releases positive Phase 3 data for Jaypirca and Retevmo, with trial results supporting potential label expansion.

Via Benzinga

Eli Lilly & Co (NYSE:LLY) Presents a Prime Case for Affordable Growth Investing ↗

April 13, 2026

Eli Lilly (LLY) exemplifies the GARP strategy with strong growth, reasonable valuation relative to peers, and robust profitability for sustainable returns.

Via Chartmill

3 Mid-Cap Stocks Walking a Fine Line

April 13, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

1 Profitable Stock to Own for Decades and 2 That Underwhelm

April 13, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

The Post-Ozempic Economy? 2 Industries Bracing for a Slimmer, Less Hungry America ↗

April 12, 2026

The use of weight-loss drugs is growing like crazy and changing the entire consumer economy along with it.

Via The Motley Fool

Topics Artificial Intelligence Economy

Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire ↗

April 11, 2026

And it's not too late to get in on the action.

Via The Motley Fool

Here's Why Buying This Vanguard Index Fund Today Could Be the Best Financial Decision You Ever Make ↗

April 10, 2026

The Vanguard S&P 500 ETF is a no-brainer for investors seeking more diversification in their portfolio.

Via The Motley Fool

Topics Artificial Intelligence ETFs Earnings

Amazon (AMZN) Stock Trades Up, Here Is Why

April 09, 2026

What Happened? Shares of cloud computing and online retail behemoth Amazon (NASDAQ:AMZN) jumped 4.5% in the afternoon session after CEO Andy Jassy's annual s...

Via StockStory

Topics Artificial Intelligence

The Global Pantry Reimagined: Unilever and McCormick Seal $65 Billion Merger Deal

April 09, 2026

In a move that has sent shockwaves through the global consumer staples market, Unilever (NYSE:UL) and McCormick & Company (NYSE:MKC) have officially entered into a definitive agreement to merge...

Via MarketMinute

Topics Economy Supply Chain

Eli Lilly Just Launched Its $149 Obesity Pill ↗

April 09, 2026

Eli Lilly launches Foundayo weight-loss pill after FDA approval, priced from $149/month, as competition with Novo Nordisk intensifies.

Via Benzinga

What to Expect From Eli Lilly's Next Quarterly Earnings Report

April 09, 2026

Eli Lilly is approaching its first-quarter earnings release this month, and Wall Street is forecasting a triple-digit percentage rise in earnings.

Via Barchart.com

Topics ETFs

What's Going On With GoodRx Stock Thursday? ↗

April 09, 2026

GoodRx shares rise after expanding Eli Lilly's GLP-1 access; analysts keep Buy rating ahead of May earnings.

Via Benzinga

Eli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales ↗

April 09, 2026

Eli Lilly and Co. is facing mounting pressure in India as a surge rise in lower-cost generic alternatives dent sales.

Via Benzinga

Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks

April 08, 2026

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, incl...

Via StockStory

Topics Artificial Intelligence Intellectual Property

The "Daily Pill" Revolution: Eli Lilly’s Orforglipron Shatters Records with 25% Weight Loss

April 08, 2026

In a watershed moment for the pharmaceutical industry, Eli Lilly and Company (NYSE: LLY) has officially crossed the threshold into a new era of metabolic medicine. Freshly released data from the...

Via MarketMinute

Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker? ↗

April 08, 2026

One of these players is well-positioned for market leadership.

Via The Motley Fool

Looks Like M&A Week in 3 Different Sectors ↗

April 08, 2026

Some large merger & acquisition deals that could shake up the consumer goods and the food distribution industry, plus deals in the healthcare industry.

Via The Motley Fool

Branded Pharmaceuticals Stocks Q4 Teardown: Royalty Pharma (NASDAQ:RPRX) Vs The Rest

April 07, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Why AC Immune Stock Zoomed Almost 15% Higher Today ↗

April 07, 2026

It's getting a cash infusion from its giant pharmaceutical partner.

Via The Motley Fool

Great News for Eli Lilly Stock Investors! ↗

April 07, 2026

The weight loss segment is poised to generate lucrative profits for Eli Lilly.

Via The Motley Fool

ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside

April 07, 2026

Via AB Newswire

Is Eli Lilly Stock a Buy After a Brand New Approval? ↗

April 07, 2026

The stock's dip might be an opportunity.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.